Imperial College London-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2022

  1. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

    The Lancet, Vol. 399, Núm. 10333, pp. 1383-1390

2020

  1. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis

    Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197

  2. Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5

    Heart Rhythm, Vol. 17, Núm. 6, pp. 945-954